Beryl Drugs Limited (BOM:524606)

India flag India · Delayed Price · Currency is INR
25.46
+0.94 (3.83%)
At close: Apr 17, 2026
Market Cap129.13M +6.8%
Revenue (ttm)176.65M -12.3%
Net Income141.00K -82.3%
EPS0.03 -83.1%
Shares Out5.07M
PE Ratio915.78
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume645
Average Volume6,381
Open25.40
Previous Close24.52
Day's Range24.25 - 25.70
52-Week Range15.92 - 30.00
Beta0.01
RSI62.74
Earnings DateMay 29, 2026

About Beryl Drugs

Beryl Drugs Limited manufactures and markets pharmaceutical products in India. The company offers various branded and generic pharmaceutical formulations, bulk drugs, I.V. fluids, small volume injectables in liquid and dry powder forms, and eye and ear drops, as well as veterinary products. It also provides research and development, and contract manufacturing services. The company exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1993
Country India
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524606
Full Company Profile

Financial Performance

In fiscal year 2025, Beryl Drugs's revenue was 211.46 million, a decrease of -20.89% compared to the previous year's 267.30 million. Earnings were 5.79 million, a decrease of -24.69%.

Financial Statements